info@quantimol.com - 1 (800) 821-7314 - Research Use Only - B2B & B2G Only - Not For Private Use
SKU:QM-0140625-01
Couldn't load pickup availability
LQZ-7F, a survivin dimerization inhibitor, induces spontaneous apoptosis and synergizes with Docetaxel in prostate cancer cells. LQZ-7F dose-dependently inhibits survival of both PC-3 and C4-2 cells with IC50s of 2.99 and 2.47 μM, respectively[1].
[354543-09-2]
C14H7N9O3
349.26
O=C(C1=NON=C1N)N/N=C2C3=C(C4=NC5=NON=C5N=C4\2)C=CC=C3
Apoptosis; Survivin
97.44
DMSO : 5 mg/mL (ultrasonic; warming; heat to 60°C)
-20°C, 3 years; 4°C, 2 years (Powder)
Room Temperature
H315, H319, H320
Loading...
Total items
Product subtotal
LQZ-7F is a premium-grade research compound supplied by Quantimol for laboratory and scientific applications.